CEN

본문 바로가기

Company

Our Team

	Dr. Han Sang-Cheol, Ph.D., Founder, CEO & CTO Dr. Han completed his doctorate in the field of nanomaterials under the guidance of Prof. Park Sang-Eon. He has served as a research member of the Korea Research Institute of Chemical Technology and worked with foreign and domestic companies. He discovered, developed, and successfully commercialized biomineralization of the mass production technologies and mechanisms for mesoporous silica nanospheres(MSN) and MSN containing encapsulated nano metal nanoparticles(SMBTM). His success led to CEN Group's founding. He has published about 23 SCI journals, 26 patents, and 30 conferences presentations.
	Dr. Shin Yong-Il, M.D., Ph.D., COO, Chief operating officer Professor Shin is the head of the Department of Rehabilitation Medicine, Pusan National University School of Medicine. He is also a director in Yeoungnam Regional Rehabilitation Hospital of Pusan National University, Yangsan Hospital. He graduated from Chonbuk National University School of Medicine and received a doctorate in medicine in 2003 and subsequently a Ph.D. He published more than 160 papers in the medical literature and holds 9 patents in the research field. His main clinical fields are neurorehabilitation for stroke, traumatic brain injury, dementia, & other CNS diseases.
	Dr. Kim Young-Soo, Ph.D., CEO, NANO Division Dr. KIM received a bachelor's degree in Mechanical Engineering from Pusan National University and a master's degree in Mechanical Eng. From Seoul National University and a doctorate degree in Mechanical Engineering from Concordia University, Canada in 1995. From 1984 to 2010 (26 years), he was a professor at the Department of Refrigeration Engineering, Pukyong National University. During his tenure, he served as director of the Eco-Friendly Advanced Energy Research Institute. His research has been mainly performed in the field of energy conversion engineering such as freeze-drying systems, hydrogen liquefaction systems, etc. His current research interests include applying Graphene Nano Plates (GNP) technology, Silica Nano Tube (SNT) and Silica Mesoporous Ball (SMB) technology, and Silica-Graphene Convergence Technology from an engineering point of view.
	Dr. Park Sang-Eon, Ph.D., Head of R&D Dr. Park is an Emeritus Professor of Inha University, Incheon, Korea. He has led the Laboratory of Nano-Green Catalysis and Nano Center for Fine Chemicals Fusion Technology for 15 years as a director and as the principal investigator at Korea Research Institute of Chemical Technology, Daejeon, Korea for 16 years and as the Process Engineer at Inchon Engineering Company in Seoul for 8 years. Professor Park has served on the editorial boards of several scientific journals and as an advisory member of several leading international conferences, including International Mesoporous and Mesostructured Materials. Specifically, he launched the Journal of CO2 Utilization and is serving as the Editor-in-Chief. His scientific achievements include the publication of more than 400 papers in the scientific literature and 75 patents with 7 commercialization.
	Chung Dong Soo, J.D., Attorney-at-Law USA, Advisor Mr. Chung graduated from Harvard University with honors (BA) in 1977, Public Administration & International Affairs at Princeton University (MA) in 1980, and UCLA School of Law (JD) in 1984. He has a distinguished career as a lawyer in the USA and Korea. Started practicing law in Los Angeles, California in 1984, established a law firm in 1988. He joined the Clinton Administration as a presidential appointee at the International Trade Administration, Department of Commerce for 7 years. Served as the Director of the Advocacy Center for 5 years, advocating the interests of the US businesses and helping them win orders in excess of $100 billion. After 32 years in the US, he moved back to Korea in 2006 and was soon appointed as the Head of Invest KOREA, overseeing the inbound foreign direct investment for 4 years, bringing over $10 billion in FDI per year. He accompanied President Lee Myung Bak as a task force member to win the nuclear power plant order from the UAE. He practiced law as a senior foreign counsel at Yulchon LLC, one of the largest in Korea, for 13 years until the end of 2021, focusing on corporate law, international trade and investment, and cross-border dispute resolution. He oversaw the firm's offices in SE Asia, including Vietnam, Myanmar, and Indonesia. He also oversaw the firm's healthcare practice group for several years. He served as a co-chair of the Pharmaceutical Committee of the American Chamber of Commerce in Korea for 10 years and has been serving as Korea's representative to the Healthcare Committee of the Business at OECD since 2019.
	Ghim Youngjin Andrew, MBA, CMO & Head of Compliance Founding CEO of UniBank, Korean-American Bank, Seattle, Washington, he worked in the areas of International Banking, Trade Finance, Corporate Banking, Investment Banking and Retail Banking for 28 years. ·1969 migrated to Brazil, a middle school in Sao Paulo. ·1972 moved to California ·1975 graduated Los Angeles High School ·1979 UCLA (Biology) & UCSB (Business Economics) BA ·1981 UCLA & UCI joint-degree MBA, International Finance and Commerce ·1981 Arthur Young & Co (Audit) ·1982 First Interstate Bank HQ ·1984 FIB California (Korea Desk) ·1986 FIB Washington (Head of Trade Finance) ·1988 FIB California Seoul Branch & FI Trading Company Korea (VP) ·1992 National Commercial Bank of Saudi Arabia (NE Asia Regional Manager) ·1994 introduced Islamic Banking to Korea for Daewoo Group’s Pakistan Highway Project ·1998 financed more than U$1.2 billion to the major banks and the leading trading companies of Korea during the IMF Asian financial crisis ·2001 Arab Banking Corporation, Singapore (Asia Regional Manager) ·2003 Riyad Bank, Singapore (Asia Regional Manager) ·2005 established UniBank ·repatriated to Korea in 2009 ·worked for various Korean companies as CEO and Chief Advisor for developing overseas markets ·speaks Korean, English, Portuguese, Spanish, Mandarin Chinese